According to the research report, the global protein expression market size is expected to touch USD 10.38 Billion by 2032, from USD 3.84 Billion in 2022, growing with a significant CAGR of 10.45% from 2023 to 2032.
The protein expression report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global protein expression in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global protein expression market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global protein expression during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2882
Report Scope of the Protein Expression Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 4.24 Billion |
| Market Size by 2032 | USD 10.38 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 10.45% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Expression System, By Product, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation of the global protein expression market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global protein expression market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Agilent Technologies Inc.,
- Bio-Rad Technologies,
- Thermo Fisher Scientific Inc.,
- Merck KGA,
- Takara Bio Inc.,
- New England Biolabs Inc.,
- Oxford Expression Technologies Ltd,
- Promega Corporation,
- Qiagen NV
- Sigma-Aldrich Corporation.
Market Segmentation
By Expression System
- Prokaryotic
- Mammalian Cell
- Insect Cell
- Yeast
- Others
By Product
- Reagents
- Competent Cells
- Expression Vectors
- Services
- Instruments
By Application
- Therapeutic
- Industrial
- Research
By End-use
- Pharmaceutical & Biotechnological Companies
- Academic Research
- Contract Research Organizations
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global protein expression report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global protein expression market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Protein Expression Market
5.1. COVID-19 Landscape: Protein Expression Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Protein Expression Market, By Expression System
8.1. Protein Expression Market, by Expression System, 2023-2032
8.1.1. Prokaryotic
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Mammalian Cell
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Insect Cell
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Yeast
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Protein Expression Market, By Product
9.1. Protein Expression Market, by Product, 2023-2032
9.1.1. Reagents
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Competent Cells
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Expression Vectors
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Services
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Instruments
9.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Protein Expression Market, By Application
10.1. Protein Expression Market, by Application, 2023-2032
10.1.1. Therapeutic
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Industrial
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Research
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Protein Expression Market, By End-use
11.1. Protein Expression Market, by End-use, 2023-2032
11.1.1. Pharmaceutical & Biotechnological Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Protein Expression Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.1.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End-use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.2.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.3.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.4.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End-use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End-use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Expression System (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 13. Company Profiles
13.1. Agilent Technologies Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Technologies
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck KGA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Takara Bio Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. New England Biolabs Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Oxford Expression Technologies Ltd
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Promega Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Qiagen NV
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Sigma-Aldrich Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments